546PTUMOUR SHRINKAGE AND RESPONSE OUTCOMES DURING SECOND-LINE PANITUMUMAB (PMAB) + FOLFIRI VS FOLFIRI TREATMENT._html_urlhttp://annonc.oxfordjournals.org/content/25/suppl_4/iv186.2.abstractdoi:10.1093/annonc/mdu333.48Peeters, M... M Peeters,TJ Price,A Cervantes,... - 《Annals of Oncology》 ...
Panitumumab (pmab) regimen evaluation in colorectal cancer to estimate primary response to treatment (PRECEPT): Effect of KRAS mutation status on second-line treatment (tx) with pmab and FOLFIRI Panitumumab (pmab) regimen evaluation in colorectal cancer to estimate primary response to treatment (...